Clinical Trial Update: Single cEll pRofiling PErsistaNce To ImmuNothErapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating single-cell profiling to support immunotherapy in colorectal cancer and endometrial cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Endometrial Cancer

Snippet

Sponsor: Vall d'Hebron Institute of Oncology | Conditions: Colorectal Cancer, Endometrial Cancer | Phase 2 | Status: RECRUITING